Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 209-639-1 | CAS number: 589-18-4
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Skin sensitisation
Administrative data
- Endpoint:
- skin sensitisation: in chemico
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- July - December 2017
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 018
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 442C (In Chemico Skin Sensitisation: Direct Peptide Reactivity Assay (DPRA))
- Version / remarks:
- 2015
- GLP compliance:
- yes (incl. QA statement)
- Remarks:
- The Department of Health of the Government of the United Kingdom, UK
- Type of study:
- direct peptide reactivity assay (DPRA)
Test material
- Reference substance name:
- 4-methylbenzyl alcohol
- EC Number:
- 209-639-1
- EC Name:
- 4-methylbenzyl alcohol
- Cas Number:
- 589-18-4
- Molecular formula:
- C8H10O
- IUPAC Name:
- (4-methylphenyl)methanol
Constituent 1
In chemico test system
- Details on the study design:
- The DPRA is an in chemico method which quantifies the remaining concentration of cysteine-or lysine-containing peptide following 24 hours incubation with the test chemical at 25ºC. The synthetic peptides contain phenylalanine to aid in the detection. Relative peptide concentration is measured by high-performance liquid chromatography (HPLC) with gradient elution and UV detection at 220 nm. Cysteineand lysine peptide percent depletion values are then calculated and used in a prediction model which allows assigning the test chemical to one of four reactivity classes used to support the discrimination between sensitisers and non-sensitisers.
Used Chemicals:
Synthetic peptide containing Cysteine: Batch 1556171, Purity 95% (by HPLC), Ac-RFAACAA-OH
Synthetic peptide containing Lysine: Batch 1556172, Purtiy 94% (by HPLC), Ac-RFAAKAA-OH
Cinnamic Aldehyde (Positive control): Batch MKBR2427V, Purity 98.7%
Apparatus:
High performance liquid chromatograph (HPLC): Waters Alliance 2695 separation module and 2487 dual wavelength detector
Balances fitted with printers: Capability of weighing to 5 decimal places
General laboratory apparatus and glassware.
Preparation of Peptide Stock Solutions:
Stock solutions of each peptide at concentrations of 0.667 mM were prepared by dissolution of pre-weighed aliquots of the appropriate peptide in ca 20 mL aliquots of the appropriate buffer solution (Cysteine in 100 mM phosphate buffer pH 7.5, Lysine in 100 mM Ammonium acetate buffer pH 10.2).
Preparation of Peptide Calibration Standards:
Calibration standards of both peptides were prepared by diluting the requisite stock solution in the appropriate buffer and acetonitrile and contained each peptide at concentrations of 0.0167 mM, 0.0334 mM, 0.0667 mM, 0.133 mM, 0.267 mM and 0.534 mM. A buffer blank was prepared as well.
Preparation of Stability Controls and Precision Controls:
Stability controls (Reference Control B) and precision controls of both peptides were prepared at a concentration of 0.5 mM in acetonitrile.
Preparation of Positive Control Stock Solution and Test Item Stock Solution:
100 mM stock solutions in acetonitrile of the positive control chemical (Cinnamic Aldehyde) and the test item were prepared.
Preparation of Positive Control and Cysteine Peptide Depletion Samples and Co-elution Controls:
Acetonitrile solutions of the test item and the positive control were diluted with the Cysteine peptide to prepare solutions containing 0.5 mM Cysteine and 5 mM of either the test item or the positive control. For the co-elution control, buffer solution was used in place of the Cysteine stock solution.
Preparation of Positive Control and Lysine Peptide Depletion Samples and Co-elution Controls:
Acetonitrile solutions of the test item and the positive control were diluted with the Lysine peptide to prepare solutions containing 0.5 mM Lysine and 25 mM of either test item or the positive control. For the co-elution control, buffer solution was used in place of the Lysine stock solution.
Incubation:
The appearance of the test item and positive control samples in the HPLC vials was documented after preparation and then the vials placed into the autosampler of the HPLC set at 25°C for a minimum of 22 hours incubation prior to initiation of the analysis run. Prior to initiation of the run the appearance of the samples in the vials was assessed and documented again.
Results and discussion
- Positive control results:
- Positive control values for cystein: 71,3 %, SD 0.25 %
Positive control values for lysine: 44.6 %, SD 0.87 %
The mean percent peptide depletion value of the three replicates for the positive control cinnamic aldehyde should be between 60.8% and 100% for the cysteine peptide and between 40.2% and 69.0% for the lysine peptide and the maximum standard deviation (SD) for the positive control replicates should be <14.9% for the percent cysteine depletion and <11.6% for the percent lysine depletion. The critera are met.
In vitro / in chemico
Resultsopen allclose all
- Key result
- Run / experiment:
- other: 1
- Parameter:
- other: cystein depletion (%)
- Value:
- -2.26
- Vehicle controls validity:
- not examined
- Negative controls validity:
- not examined
- Positive controls validity:
- valid
- Key result
- Run / experiment:
- other: 1
- Parameter:
- other: Mean lysine depletion (%)
- Value:
- -0.08
- Vehicle controls validity:
- not examined
- Negative controls validity:
- not examined
- Positive controls validity:
- valid
- Other effects / acceptance of results:
- All analytical acceptance criteria were met:
Acceptance criteria for Cysteine and Lysine (Standard Linearity): r²>0.99, achieved results: r²>0.999
Acceptance criteria for Cysteine and Lysine respectively (Reference controls): 0.45-0.55 mM (CV <14.9%) and 0.45-0.55 mM (CV <11.6%), achieved results: B: 0.499 mM (CV 0.75%, n=6) and B: 0.504 mM (CV 0.32%, n=6)
Acceptance criteria for Cysteine and Lysine (Test item): SD<14.9% and SD<11.6%, achieved results: SD 0.43% (n=3) and SD 0.30% (n=3)
Reactivity is classed as no to minimal, the DPRA prediction is negative and the test item is therefore a potential non skin sensitizer. A partial co-elution peak was observed in the Cysteine assay, however this is considered to be of minimal impact as the cysteine peak was consistently integrated in all three sample chromatograms. No co-elution peaks occurred in the Lysine assay.
Any other information on results incl. tables
Table 5: Individual Achieved Depletion Values of Cysteine Peptide Depletion
Sample |
Peak area (μV.sec) |
Peptide concentration(μg/mL) 1 |
Peptide Depletion (%) 2 |
Mean Depletion (%) |
SD (%) |
Positive control |
253903 |
107.35 |
71.4 |
71.3 |
0.25 |
257128 |
108.71 |
71.0 |
|||
252885 |
106.91 |
71.5 |
|||
Test item |
902625 |
382.01 |
-1.72 |
-0.179 |
0.43 |
899767 |
380.80 |
-1.40 |
|||
907371 |
384.02 |
-2.26 |
SD Standard Deviation
1 Samples prepared at a concentration of 376 μg/mL (0.5 mM)
2 Calculated against a mean Reference Control area of 887340 μV.sec (n=6)
Table 6: Individual Achieved Depletion Values of Lysine Peptide Depletion
Sample |
Peak area (μV.sec) |
Peptide concentration (μg/mL) 1 |
Peptide Depletion (%) 2 |
Mean Depletion (%) |
SD (%) |
Positive control |
428621 |
212.34 |
45.6 |
44.6* |
0.87 |
439007 |
217.50 |
44.3 |
|||
441606 |
218.79 |
43.9 |
|||
Test item |
784117 |
389.07 |
0.456 |
0.112 |
0.30 |
788402 |
391.20 |
-0.0880 |
|||
787965 |
390.98 |
-0.0320 |
SD Standard Deviation
1 Samples prepared at a concentration of 388μg/mL (0.5 mM)
2 Calculated against a mean Reference Control area of 787710 μV.sec (n=6)
* Individual and mean results are all outside of the historical data achieved parameters however all results are within acceptance criteria for the assay.
Applicant's summary and conclusion
- Interpretation of results:
- other: no skin sensitizing potential based on the key event "protein reactivity"
- Conclusions:
- In the Direct Peptide Reactivity Assay (DPRA) according to OECD 422C the test item showed no to minimal reactivity and is therefore predicted to be a non-skin sensitizer.
- Executive summary:
The purpose of this study (based on the OECD guideline for the testing of chemicals, In chemico Skin Sensitisation: Direct Peptide Reactivity Assay (DPRA), OECD/OCDE document TG 442C) was to assess the reactivity and sensitizing potential of the test item. All analytical acceptance criteria for each peptide run were met. Solutions of the test item were successfully analysed by the validated DPRA analytical method (Envigo analytical method FIA/M101/15) in both Cysteine and Lysine containing synthetic peptides. There was no reactivity (no depletion) in the presence of either peptide which places the test item in the reactivity class of “no or minimal reactivity” and therefore it is predicted by DPRA to be a non-skin sensitizer.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.